Corporate Tech Investors

Roivant Sciences

Roivant Sciences is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Roivant was founded in May 2014. Today we have a team of several hundred staff members, a strong capital base, and a pipeline of 23 drugs across our family of companies. At present our subsidiaries include Axovant, Dermavant, Enzyvant, Genevant, Metavant, Myovant, Urovant, Arbutus, and Datavant. And we're just getting started.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/5/2023

Transaction History

Our records indicate that Roivant Sciences invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Vivek Ramaswamy

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Roivant Sciences has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Rogers Ventures | Rolling Bay Ventures

Share this article

About Our Corporate Tech Investor Database

The strategic investor data above is provided by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary